Evidence map›Paper›PMID 29685622›Full record

ArticleNutrition research (New York, N.Y.)2018

Early dietary restriction in rats alters skeletal muscle tuberous sclerosis complex, ribosomal s6 and mitogen-activated protein kinase.

Kara L Calkins, Shanthie Thamotharan, Yun Dai, Bo-Chul Shin, Satish C Kalhan, Sherin U Devaskar

Open access · greenAbstract read
In one paragraph

Article in Nutrition research (New York, N.Y.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Kara L CalkinsDepartment of Pediatrics, Division of Neonatology & Developmental Biology, Neonatal Research Center of the UCLA Children's Discovery and Innovation Institute, David Geffen School of Medicine UCLA, 10833 Le Conte Ave, Los Angeles, CA 90095-1752. Electronic address: Kcalkins@mednet.ucla.edu.
Shanthie ThamotharanDepartment of Pediatrics, Division of Neonatology & Developmental Biology, Neonatal Research Center of the UCLA Children's Discovery and Innovation Institute, David Geffen School of Medicine UCLA, 10833 Le Conte Ave, Los Angeles, CA 90095-1752. Electronic address: SThamotharan@mednet.ucla.edu.
Yun DaiDepartment of Pediatrics, Division of Neonatology & Developmental Biology, Neonatal Research Center of the UCLA Children's Discovery and Innovation Institute, David Geffen School of Medicine UCLA, 10833 Le Conte Ave, Los Angeles, CA 90095-1752. Electronic address: arieldatabase2014@gmail.com.
Bo-Chul ShinDepartment of Pediatrics, Division of Neonatology & Developmental Biology, Neonatal Research Center of the UCLA Children's Discovery and Innovation Institute, David Geffen School of Medicine UCLA, 10833 Le Conte Ave, Los Angeles, CA 90095-1752. Electronic address: BShin@mednet.ucla.edu.
Satish C KalhanDepartment of Pathobiology, Lerner Research Institute, Cleveland Clinic, 9620 Carnegie Ave, Cleveland, OH 44106. Electronic address: sck@case.edu.
Sherin U DevaskarDepartment of Pediatrics, Division of Neonatology & Developmental Biology, Neonatal Research Center of the UCLA Children's Discovery and Innovation Institute, David Geffen School of Medicine UCLA, 10833 Le Conte Ave, Los Angeles, CA 90095-1752. Electronic address: SDevaskar@mednet.ucla.edu.
Mattel Children's Hospital · USCleveland Clinic Lerner College of Medicine · US

Funding

UCLA Child Health Research Career Development AwardK12HD034610 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DEVASKAR, SHERIN U · 2002 to 2017
$6.6M
Prenatal Metabolic Programming of the OffspringR01HD041230 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DEVASKAR, SHERIN U · 2001 to 2019
$5.2M
Building Interdisciplinary Research Careers in Women's Health (BIRCWH) CenterK12HD001400 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CHAUDHURI, GAUTAM · 2000 to 2009
$4.2M
Prenatal Origins of Neurometabolic ConsequencesR01HD081206 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DEVASKAR, SHERIN U · 2015 to 2024
$4.1M
POSTNATAL ASPECTS OF A GLUCOSE TRANSPORTERR01HD033997 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DEVASKAR, SHERIN U · 1995 to 2008
$3.1M
PERINATAL METABOLIC AND HORMONAL EFFECTSR01HD025024 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DEVASKAR, SHERIN U · 1996 to 2010
$2.6M
NICHD NIH HHS K12 HD001400NICHD NIH HHS K12 HD034610NICHD NIH HHS R01 HD025024NICHD NIH HHS R01 HD033997NICHD NIH HHS R01 HD041230NICHD NIH HHS R01 HD081206
6 · The paper itself

Abstract

Intrauterine growth restriction is linked to decreased lean body mass and insulin resistance. The mammalian target of rapamycin (mTOR) regulates muscle mass and glucose metabolism; however, little is known about maternal dietary restriction and skeletal muscle mTOR in offspring. We hypothesized that early dietary restriction would decrease skeletal muscle mass and mTOR in the suckling rat. To test this hypothesis, ab libitum access to food or dietary restriction during gestation followed by postnatal cross-fostering to a dietary-restricted or ad libitum-fed rat dam during lactation generated 4 groups: control (CON), intrauterine dietary restricted (IUDR), postnatal dietary restricted (PNDR), and IUDR+PNDR (IPDR). At day 21, when compared to CON, the IUDR group demonstrated "catchup" growth, but no changes were observed in the mTOR pathway. Despite having less muscle mass than CON and IUDR (P < .001), in IPDR and PNDR rats mTOR remained unchanged. IPDR and PNDR (p)-tuberous sclerosis complex 2 was less than the IUDR group (P < .05). Downstream, IPDR's and PNDR's phosphorylated (p)-ribosomal s6 (rs6)/rs6 was less than that of CON (P < .05). However, male IPDR's and PNDR's p-mitogen activated protein kinase MAPK/MAPK was greater than CON (P < .05) without a change in p90 ribosomal s6 kinase (p90RSK). In contrast, in females, MAPK was unchanged, but IPDR p-p90RSK/p90RSK was less than CON (P = .01). In conclusion, IPDR and PNDR reduced skeletal muscle mass but did not decrease mTOR. In IPDR and PNDR, a reduction in tuberous sclerosis complex 2 may explain why mTOR was unchanged, whereas, in males, an increase in MAPK with a decrease in rs6 may suggest a block in MAPK signaling.

Indexed as

Caloric RestrictionEnergy IntakeMaternal Nutritional Physiological PhenomenaAnimalsBody CompositionFemaleFetal Growth RetardationInsulin ResistanceLactationMaleMitogen-Activated Protein KinasesMuscle, SkeletalPhosphorylationRats, Sprague-DawleyRibosomal Protein S6 Kinases, 90-kDaSignal TransductionMitogen-Activated Protein KinasesRibosomal Protein S6 Kinases, 90-kDaTOR Serine-Threonine KinasesDiet reducingFetal growth retardationMitogen-activated protein kinase phosphatasesMuscle, skeletalRatsTOR serine-threonine kinase

Identifiers

PMID29685622
PMCPMC6008232
OpenAlexW2792851038

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.